CoChat

Characterization of dermatitis after PD-1/PD-L1 inhibitor therapy and association with multiple oncologic outcomes: A retrospective case-control study

Open access
Min Lee, Charles Kyung, Li, Shufeng, Tran, Duy Cong, Zhu, Gefei Alex, Kim, Jinah, Kwong, Bernice Y., Chang, Anne Lynn S. · 2018 · Journal of the American Academy of Dermatology
Cited by 119

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Cutaneous adverse events are common with programmed death 1 (PD‐1)/programmed death ligand 1 (PD‐L1) inhibitors. However, the nature of the specific cutaneous adverse event of dermatitis has not been investigated across various PD‐1/PD‐L1 inhibitors. Oncologic outcomes potentially associated with dermatitis are not well characterized. Objective: To assess the nature of dermatitis after exposure to a PD‐1/PD‐L1 inhibitor and oncologic outcomes associated with dermatitis. Methods: Retrospective, matched, case‐control study conducted at a single academic center. Results: The most common histologic patterns were lichenoid dermatitis (50%) and spongiotic dermatitis (40%). The overall tumor response rate was 65.0% for the case patients and 17.0% for the controls (P = .0007) (odds ratio, 7.3; 95% confidence interval, 2.3‐23.1). The progression‐free survival and overall survival times were significantly longer for the case patients than for the controls by Kaplan‐Meier analysis (P < .0001 and .0203, respectively). Limitations: The retrospective design and relatively small sample size precluded matching for all cancer types. Conclusions: Lichenoid and spongiotic dermatitis associated with PD‐1/PD‐L1 inhibitors could be a sign of robust immune response and improved oncologic outcomes. The value of PD‐1/PD‐L1–related dermatitis in predicting cancer outcomes awaits investigation through prospective multicenter studies for specific cancer types.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaad.2018.05.035

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

Metadata

Authors
Min Lee, C. K., Li, S., Tran, D. C., Zhu, G. A., Kim, J., Kwong, B. Y., & Chang, A. L. S.
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
2018-12
Volume
79
Issue
6
Pages
1047-1052
ISSN
0190-9622 (ISSN-L)
OpenAlex
W2805602843
Cited by
119
References
6
FWCI
5.65
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.